SCHEMBL12153088

SCHEMBL12153088

N[C@@H]1Cc2ccccc2CN(CC(F)(F)F)C1=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 2/20 0.45
▸ AADAT Q8N5Z0 8/20 0.44
▸ GOT1 P17174 1/20 0.44
▸ KYAT1 Q16773 1/20 0.44
▸ KYAT3 Q6YP21 1/20 0.44
▸ OPRM1 P35372 2/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC9 Q9UKV0 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ ITGB3 P05106 3/20 0.37
▸ ITGAV P06756 3/20 0.37
▸ ITGA2B P08514 2/20 0.37
▸ TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4738589 0.80 ANPEP (0.49) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL30320121 0.77 ACE (0.53) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL199254 0.77 ACE (0.53) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL3870683 0.77 ACE (0.53) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL12893386 0.75 OPRM1 (0.47) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL12153004 0.72 CYP2A6 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC8
SCHEMBL12626584 0.71 AADAT (0.51) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL4491852 0.71 AADAT (0.51) ANPEPAADATGOT1KYAT1KYAT3
SCHEMBL3728881 0.70 KDM4E (0.54) HDAC3HDAC4HDAC1HDAC7HDAC8
SCHEMBL7443272 0.68 HRH4 (0.42) ANPEPAADATGOT1KYAT1KYAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613368-B1 CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2011-11-30 — — EP disclosed
EP-1796678-B1 CARBOXAMIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2010-04-14 — — EP disclosed
US-7390798-B2 Carboxamide spirolactam CGRP receptor antagonists MERCK & CO., INC. (US) 2008-06-24 — — US disclosed
US-7390798-B2 Carboxamide spirolactam CGRP receptor antagonists MERCK & CO., INC. (US) 2008-06-24 — — US disclosed
US-20070293470-A1 Carboxamide Spirolactam Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2007-12-20 — — US disclosed
US-20070293470-A1 Carboxamide Spirolactam Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2007-12-20 — — US disclosed
US-7288559-B2 Carboxamide spirohydantoin CGRP receptor antagonists MERCK + CO, INC. (US) 2007-10-30 — — US disclosed
US-20070111982-A1 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides MERCK SHARP & DOHME LLC 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293470-A1 Carboxamide Spirolactam Cgrp Receptor Antagonists BDKRB1, CALCRL, BDKRB2 ANPEP 1979/4885AADAT 3078/4885GOT1 4300/4885
US-20070111982-A1 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides CALCA, CALCRL, CALCB ANPEP 691/4885AADAT 2628/4885GOT1 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback